The North America Protein Purification & Isolation Market is experiencing significant growth driven by technological advancements and the increasing focus on precision medicine. The market size was valued at USD 3,720 Million in 2025 and is expected to reach USD 7,910 Million by 2035, expanding at a CAGR of 7.3% from 2024 to 2035.
The economic impact of tariffs on "North America Protein Purification & Isolation Market".
Market Growth Drivers
Rising demand for recombinant proteins for therapeutic applications is a key growth driver for the North American protein purification & isolation market. Leading companies like Thermo Fisher Scientific are investing in advanced purification technologies to meet the needs of the rapidly growing biotech and pharmaceutical sectors, particularly in monoclonal antibodies, vaccines, and other biologics. The ongoing expansion of research and development pipelines and FDA approvals for biologically derived drugs further boost demand for high-purity protein isolation methods.
Expansion in academic and government-funded research institutions is fueling market growth. Greater federal investments in proteomics and genomics studies across the U.S. and Canada have stimulated the need for advanced protein purification solutions. Companies like Merck KGaA (MilliporeSigma) are collaborating with universities and research centers, providing products and expertise to facilitate protein-based research, drug discovery, and biomarker identification, driving increased adoption of protein purification & isolation technologies.
Market Trends
Automation and miniaturization of protein purification workflows are key trends shaping the North America market. Companies including Cytiva (formerly GE Healthcare Life Sciences) are introducing automated platforms and microfluidics-based systems that allow high throughput with less manual intervention, higher reproducibility, and lower sample consumption. This adoption is accelerating in both academic and industrial settings as it shortens experiment timelines and reduces costs related to labor and reagents.
Integration of artificial intelligence (AI) and machine learning in protein analysis is transforming the market. Businesses like Bio-Rad Laboratories are leveraging AI-driven algorithms into their purification systems, which enables optimization of process parameters in real time, improves yield, and reduces bottlenecks. Such technological innovations enhance efficiency and accuracy, paving the way for next-generation protein purification processes that can handle complex and diverse samples.
Market Opportunities
Personalized medicine and biomarker discovery present major growth opportunities in North America. As the shift toward individualized therapies accelerates, companies like Agilent Technologies are developing customizable protein isolation solutions for precise characterization. This equips pharmaceutical developers and clinical researchers to better study patient-specific proteomics, making treatments more targeted and effective.
Expansion into emerging therapeutic areas such as cell and gene therapy offers new markets for protein purification technologies. Revvity (PerkinElmer) has begun tailoring products to cater to unique protein requirements in these innovative fields, presenting additional revenue streams for key market participants.
North America Protein Purification & Isolation Market Revenue (USD Million), 2020-2035
The revenue chart illustrates consistent and significant growth in the North American protein purification & isolation market between 2020 and 2035. Starting at USD 2,160 Million in 2020, the market grows steadily, propelled by advances in biotechnology research, increasing biopharmaceutical production, and expanding applications in clinical and academic sectors. The upward trajectory is further fueled by technological innovations and growing investments, with the market expected to nearly quadruple by 2035, reaching USD 7,910 Million. The data clearly reflects robust demand and high growth potential in the region across the forecast period.
North America Protein Purification & Isolation Market Share by Region, 2025 (%)
The 2025 regional market share distribution demonstrates the United States holding the dominant position with 74% market share, attributed to the presence of leading biopharmaceutical companies, well-established research infrastructure, and significant federal funding. Canada follows with 20%, bolstered by active government initiatives in biomedical R&D. Mexico, with 4%, is gradually emerging due to growing clinical research and investments. The remaining 2% is shared among other North American territories. This regional distribution highlights the concentration of advanced life sciences activities and market opportunities primarily within the U.S. and Canada.
Recent Developments
In February 2024, Thermo Fisher Scientific launched its new Gibco™ Purification System, an automated solution designed to scale protein production and purification for both research and pharmaceutical applications. This launch was accompanied by collaborations with leading biotech firms in California to advance monoclonal antibody purification, expanding Thermo Fisher’s footprint in the North American protein isolation market.
In March 2024, MilliporeSigma (the U.S. and Canada life science business of Merck KGaA) announced a strategic partnership with a major Canadian research institute to provide next-generation protein purification workflows. The collaboration leverages MilliporeSigma’s proprietary chromatography resin technology to support proteomics studies involved in cancer biomarker discovery and personalized medicine.
In April 2024, Cytiva invested USD 50 Million to open a new life sciences innovation center in Massachusetts, with a significant focus on protein purification platform R&D. The center aims to accelerate novel protein and antibody isolation methods, facilitating faster movement of biological therapeutics from laboratory to market.
Press Releases